Lacosamide-13C, D3 solution

Descrição detalhada : An internal standard suitable for GC/MS or LC/MS applications in lacosamide testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods. Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat(R).
Fórmula molecula r: 13CC12D3H15N2O3
Armazenamento : -20C
Embalagem : 1X1ML